<DOC>
	<DOC>NCT01536158</DOC>
	<brief_summary>The purpose of this study is to determine whether oral paracetamol or ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosus in preterm infants.</brief_summary>
	<brief_title>Oral Paracetamol Versus Oral Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Infants: A Randomised Controlled Trial</brief_title>
	<detailed_description>To determine whether oral paracetamol or ibuprofen has a better or same efficacy and tolerance in closure of patent ductus arteriosus in preterm infants. Eighty preterm infants with patent ductus arteriosus will be enrolled in this prospective-randomized study. Patients will receive oral ibuprofen at an initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 h or oral paracetamol 15 mg/kg per dose every 6 hours. One of the following echocardiographic criteria of a duct size &gt;1.5 mm, a left atrium-to-aorta ratio &gt;1.5, left-to-right shunting of blood, end diastolic reversal of blood flow in the aorta, or poor cardiac function in addition signs of patent ductus arteriosis determined the need of treatment.</detailed_description>
	<mesh_term>Ductus Arteriosus, Patent</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Birth weight below 1250 gram Diagnosed patent ductus arteriosus by Echocardiographic examination Accompanied other congenital cardiac anomalies Urine output of less than 1 ml/kg/h during the preceding 8 h, Serum creatinine level &gt;1.6 mg/dl, Platelet count &lt;60,000/mm3, Liver failure, Hyperbilirubinemia requiring exchange transfusion Severe intracranial bleeding (Grade III IV) Intestinal abnormality and necrotising enterocolitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Days</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Patent Ductus Arteriosus</keyword>
	<keyword>Paracetamol</keyword>
	<keyword>Ibuprofen</keyword>
	<keyword>Preterm infant</keyword>
</DOC>